Roger Jeffs
About Roger Jeffs
Roger Jeffs is the Chief Executive Officer, known for his 18-year tenure at United Therapeutics where he played a pivotal role in its growth and success.
Roger Jeffs Chief Executive Officer
Roger Jeffs serves as the Chief Executive Officer of an undisclosed organization. He previously retired as President and co-CEO of United Therapeutics in 2016 after an 18-year tenure. During his time at United Therapeutics, he played significant roles in various capacities, contributing to the company's growth and success.
Roger Jeffs Education and Expertise
Roger Jeffs holds an undergraduate degree in chemistry from Duke University and a Ph.D. in pharmacology from the University of North Carolina School of Medicine. His educational background has provided him with expertise in research, development, and clinical pharmacology.
Roger Jeffs Career Background
Roger Jeffs joined United Therapeutics Corporation in 1998 during its start-up phase as the Director of Research, Development, and Medical. He served as President and Chief Operating Officer from 2001 to 2014, and subsequently as President and co-CEO from 2015 to 2016. Before his tenure at United Therapeutics, he held positions in clinical development at Amgen, Inc. and Burroughs Wellcome Co.
Roger Jeffs Achievements
During his career at United Therapeutics, Roger Jeffs oversaw the clinical development and regulatory approval of six products for rare diseases. He also helped lead the company's IPO and managed the commercial effort that resulted in over 20% CAGR and a $1.5 billion annual revenue run rate. Jeffs received the 2015 Wings of Hope Award from the Solving Kids’ Cancer organization.
Roger Jeffs Board Memberships
Roger Jeffs has previously served on the Board of Directors for companies including United Therapeutics, Dova Pharmaceuticals, Sangamo Therapeutics, and Albireo Pharma. Currently, he is serving on the Board of Axsome Therapeutics, contributing his expertise to the governance of the company.